logo
Select company
Select metric
$ 8.45MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
64
Sector
73
Industry
75
History
79
$ 10.8Close
$ 6.56 - $ 12.79 52-Week Range
Ticker Information

Ticker

ZVRA

Company Name

ZEVRA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZEVRA THERAPEUTICS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZVRA - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ 8.45M
3/31/2025$ -5.51M
12/31/2024$ -9.26M
9/30/2024$ 10.77M
6/30/2024$ -26.94M
3/31/2024$ 2.67M
12/31/2023$ -22.42M
9/30/2023$ -26.79M
6/30/2023$ -10.58M
3/31/2023$ -60.03M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZEVRA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -1.55M.
  • Over the past 5 years, ZEVRA THERAPEUTICS INC's average CF - Chg. Cash has been $ 7.66M.
  • The median CF - Chg. Cash for ZEVRA THERAPEUTICS INC during this period was $ -3.53M
  • ZEVRA THERAPEUTICS INC reached its highest CF - Chg. Cash over the past 5 years at $ 126.05M.
  • The lowest CF - Chg. Cash recorded by ZEVRA THERAPEUTICS INC in the same timeframe $ -61.44M

ZEVRA THERAPEUTICS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
EYPT : EYEPOINT PHARMACEUTICALS INC $ -19.63MTBPH : THERAVANCE BIOPHARMA INC $ 235.58MSAGE : SAGE THERAPEUTICS INC $ -33.8MMGTX : MEIRAGTX HOLDINGS PLC $ -72.71MLXRX : LEXICON PHARMACEUTICALS INC $ 14.75MNKTR : NEKTAR THERAPEUTICS $ 15.05MKURA : KURA ONCOLOGY INC $ 36.77MGOSS : GOSSAMER BIO INC $ -60.57MNRIX : NURIX THERAPEUTICS INC $ -20.54MSNDX : SYNDAX PHARMACEUTICALS INC $ 3.24M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

ZVRA - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -61.44M

Minimum

Sep 30, 2022

$ 126.05M

Maximum

Sep 30, 2021

$ 7.66M

Average

$ -3.53M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M